ENTITY
WuXi PharmaTech Cayman

WuXi PharmaTech Cayman (WX US)

29
Analysis
Health CareChina
WuXi PharmaTech (Cayman), Inc. provides research services. The Company offers services include researching, analysis, development, and manufacturing of pharmaceutical and biotechnology products.
more
Refresh
26 Feb 2016 05:38

Coming to the HKEX Soon....................

Bloomberg has published a story (that others have cited) that WuXi Pharmatech has picked bankers for an HK listing of its biologics manufacturing...

Share
18 Feb 2016 23:01

Time to Go Shopping for Healthcare

The decline in equity markets has created opportunities to buy a variety of healthcare stocks at attractive valuations. Insider purchases have...

Share
13 Nov 2015 17:14

Quick Note - Almost at the Finishing Line

Latest Update:Glass Lewis and ISS have advised Wuxi's shareholders to approve the offer from the consortium. We believe Shareholders will vote in...

Share
05 Nov 2015 20:23

Mindray - 2 Steps back 1 Step forward

Mindray Medical International Limited ("Mindray") has announced that it has entered into a definitive Agreement with Excelsior Union Limited...

Share
13 Sep 2015 11:02

Buyout Offer Lowered to US$27/ADS from US$30/ADS

Mindray's management team has lowered its buyout offer by 10% to US$27/ADS, citing 1) the company's recent poor financial performance, 2)...

Share
x